
APPLICATION OF METHOD BASED ON IN VITRO ANTIBODY QUANTIFICATION IN PBMC SUPERNATANT SAMPLES FOR IMMUNOGENICITY EVALUATION OF A (H5N1) AND A (H5N2) POTENTIALLY PANDEMIC INFLUENZA VACCINES IN CLINICAL TRIALS
Author(s) -
Лосев Игорь Владимирович,
Svetlana Donina,
Galina Petukhova,
М. К. Ерофеева,
Larisa Rudenko,
A. N. Naikhin
Publication year - 2016
Publication title -
medicinskaâ immunologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.133
H-Index - 6
eISSN - 2313-741X
pISSN - 1563-0625
DOI - 10.15789/1563-0625-2016-2-129-138
Subject(s) - immunogenicity , virology , peripheral blood mononuclear cell , antibody , influenza a virus subtype h5n1 , vaccination , immune system , influenza vaccine , immunology , hemagglutination assay , biology , medicine , in vitro , virus , titer , biochemistry